Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment
about
Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of ChinaVirological outcomes and drug resistance in Chinese patients after 12 months of 3TC-based first-line antiretroviral treatment, 2011-2012Characteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province, ChinaThe prevalence of HIV-1 drug resistance among antiretroviral treatment naïve individuals in mainland China: a meta-analysisFactors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South AfricaRapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® SystemSuboptimal antiretroviral therapy adherence among HIV-infected adults in Guangzhou, China.Effects of patient load and travel distance on HIV transmission in rural China: Implications for treatment as prevention.HIV-1 Treatment-as-Prevention: A Cohort Study Analysis of Serodiscordant Couples in Rural Southwest China.Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China.Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.
P2860
Q28354095-E241B3E3-B80A-4605-9557-0AADE074F702Q28539652-1FC5ECD0-D0C3-41E3-9CFC-EA61A14E4472Q28539927-27A94794-949E-49C9-8D8D-53277F3C5D87Q28544113-9B327E48-8BBB-410F-BF68-DB69CEFCD037Q28546698-F7FEE1D7-0D8B-43B7-BA76-63C42FFB83D1Q28551441-AB7978F3-B04A-42E6-AEDE-E9BA3F98F4C5Q33623993-7F410D90-AC0A-40BC-BEF1-C372E0CE002BQ33745875-E38EF9FC-893E-47FA-8087-81BD8A47C89FQ36194543-7E6042E0-BA0C-47CA-A245-C2EAD606AE92Q36209093-8C6B4FFB-6C24-4F00-B82F-D02EF09D266FQ40052482-6B841F17-4107-49EE-B85E-0BABFAA23D71Q40746082-DE4CDBC8-9C38-4BC0-AE4A-1FAA25944D27Q42149889-157C360C-EC6C-4CB4-957C-2B4AF2958570
P2860
Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Incidence and associated facto ...... iving antiretroviral treatment
@ast
Incidence and associated facto ...... iving antiretroviral treatment
@en
Incidence and associated facto ...... iving antiretroviral treatment
@nl
type
label
Incidence and associated facto ...... iving antiretroviral treatment
@ast
Incidence and associated facto ...... iving antiretroviral treatment
@en
Incidence and associated facto ...... iving antiretroviral treatment
@nl
prefLabel
Incidence and associated facto ...... iving antiretroviral treatment
@ast
Incidence and associated facto ...... iving antiretroviral treatment
@en
Incidence and associated facto ...... iving antiretroviral treatment
@nl
P2093
P2860
P3181
P1433
P1476
Incidence and associated facto ...... iving antiretroviral treatment
@en
P2093
Jenny H Hsi
Jianmei He
Lingjie Liao
Liting Yang
Xiaohong Pan
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0062408
P407
P50
P577
2013-01-01T00:00:00Z